- Research article
- Open Access
Enzymatic activity of a subtilisin homolog, Tk-SP, from Thermococcus kodakarensisin detergents and its ability to degrade the abnormal prion protein
© Hirata et al; licensee BioMed Central Ltd. 2013
- Received: 19 November 2012
- Accepted: 26 February 2013
- Published: 28 February 2013
Tk-SP is a member of subtilisin-like serine proteases from a hyperthermophilic archaeon Thermococcus kodakarensis. It has been known that the hyper-stable protease, Tk-SP, could exhibit enzymatic activity even at high temperature and in the presence of chemical denaturants. In this work, the enzymatic activity of Tk-SP was measured in the presence of detergents and EDTA. In addition, we focused to demonstrate that Tk-SP could degrade the abnormal prion protein (PrPSc), a protease-resistant isoform of normal prion protein (PrPC).
Tk-SP was observed to maintain its proteolytic activity with nonionic surfactants and EDTA at 80°C. We optimized the condition in which Tk-SP functions efficiently, and demonstrated that the enzyme is highly stable in the presence of 0.05% (w/v) nonionic surfactants and 0.01% (w/v) EDTA, retaining up to 80% of its activity. Additionally, we also found that Tk-SP can degrade PrPSc to a level undetectable by western-blot analysis.
Our results indicate that Tk-SP has a great potential for technological applications, such as thermo-stable detergent additives. In addition, it is also suggested that Tk-SP-containing detergents can be developed to decrease the secondary infection risks of transmissible spongiform encephalopathies (TSE).
- Serine protease
- Hyperthermophilic archaeon
- Detergent compatibility
- Transmissible spongiform encephalopathies (TSE)
Proteases form a major part of the industrial enzyme market, and are applied to detergents as well as food, leather, and fabric processing, and are also used as catalysts in organic synthesis and as therapeutics . With the annual protease sales of about $1.5–1.8 billion, these enzymes account for 60% of the total enzyme market. Detergent proteases, particularly alkaline proteases, with an annual market of about $1 billion, account for the largest part of protease application. Subtilisin Carlsberg and related subtilisin serine proteases represent the first generation of detergent proteases with an optimal pH of 9–10. The second-generation detergent proteases, having a higher optimal pH of 10–11 and greater temperature stability, are produced from alkalophilic strains of Bacillus. The third generation consists of detergent proteases in which the active sites have been modified or various attempts have been made to enhance their stability through site-directed mutagenesis and protein engineering [2, 3].
Proteolytic enzymes from microorganisms are the most widely exploited enzymes in the detergent industries [4, 5]. These enzymes are incorporated into detergent formulations to obtain certain characteristics, such as activity and stability in high alkaline pH range and high temperatures, compatibility with compounds used in detergents such as surfactants, perfumes, and bleaches, and hydrolysis specificity towards other proteins . Therefore, there is always a need for newer hyper-stable alkaline proteases with potential application in detergent formulations.
More recently, studies on enzymatic degradation of prion protein have highlighted the ability of some proteases to digest this class of protein [7–9]. Prion diseases are fatal neurodegenerative disorders that include Creutzfeldt-Jacob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia, and kuru in humans, bovine spongiform encephalopathy (BSE) in cattle, and scrapie in sheep [10, 11]. Their central feature is the posttranslational conversion of host-encoded, cellular prion protein (PrPC) to an abnormal isoform, known as PrPSc. This transition appears to involve only a conformational change to a predominantly β-pleated structure, and confers PrPSc with partial resistance to proteolytic degradation and detergent insolubility [10–12]. PrPSc is largely unaffected by standard methods of sterilization; thus, contaminated neurosurgical instruments are the major cause of human transmissible spongiform encephalopathies (TSEs), in addition to exposure to infectious materials through the use of human cadaveric-derived pituitary hormones as well as dural and cornea homotransplants . The results of numerous studies designed to define conditions for the inactivation of PrPSc concluded that protein denaturants, such as sodium dodecyl sulfate (SDS) [13, 14], are effective in reducing infectivity, but that complete inactivation requires extremely intense conditions, such as 1 h of autoclaving at 134°C or treatment with 2 N NaOH or sodium hypochlorite for 1 h . However, such intense conditions cannot be applied to certain equipments such as endoscope. Hence, validated methods to inactivate PrPSc are highly desirable.
Thermococcus kodakarensis is a hyperthermophilic archaeon, which grows most optimally at 90°C . Its genome contains three genes encoding subtilisin-like serine proteases: Tk-subtilisin (GenBank: YP184088) , Tk-SP (GenBank: YP184102) , and Tk-0076 (GenBank: YP182489). Of these homologs, Tk-subtilisin and Tk-SP have been structurally and functionally well studied [16–27]. Tk-subtilisin and Tk-SP are highly thermostable enzymes with optimal temperature for activity in the range of 90–100°C and show broad substrate specificity. Tk-subtilisin and Tk-SP exhibit the pH dependence and temperature dependence of the activities. Tk-SP exhibits 10 to 70% of the maximal activity at a neutral pH range between 6.0 and 8.0 at 20°C. It exhibits 10 to 50% of the maximal activity at between 30 and 60°C . In particular, Tk-SP is highly resistant to heat, 5% SDS, 8 M urea, 10% Triton X-100, or 10 mM EDTA; however, unlike Tk-subtilisin and bacterial subtilisin, Tk-SP does not require Ca2+ for folding [17, 25]. Thus, Tk-SP has a great potential for technological applications.
In the present study, to examine the activity of Tk-SP in the presence of 12 surfactants (four nonionic detergents, three anionic detergents, two cationic detergents, and three amphionic detergents) and EDTA at high temperatures, Tk-SP was overproduced in E. coli and purified, and subsequently analyzed for its relative activity at 80°C and 90°C using azocasein as the substrate. We found that Tk-SP could maintain its proteolytic activity in the presence of surfactants, suggesting that this enzyme could be a candidate for industrial applications in detergent formulation.
In addition, to determine whether Tk-SP is capable of degrading PrPSc, PrPSc (Chandler strain) accumulated in scrapie-infected mouse brain homogenate (MBH) was incubated with Tk-SP and then detected by western-blot analysis. We observed that Tk-SP can disrupt PrPSc to a level undetectable by western-blot analysis, suggesting that this enzyme has a remarkable characteristic, considering its potential application for the inactivation of PrPSc.
Effect of surfactants and EDTA on Tk-SP activity
In the presence of anionic surfactants, Tk-SP was unstable, losing up to 80% of its activity. On the other hand, a previous study analyzed the activity of Tk-SP at 55°C using N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (Suc-AAPF-pNA) as the substrate, and found that the enzyme is highly resistant to 5% (w/v) SDS . This discrepancy in the findings may be due to the temperature of the reaction. In addition, the concentration of Tk-SP analyzed in the previous study was ten-fold higher than that in this study, suggesting that high concentration of Tk-SP may increase the stability. Thus, from these results, it can be concluded that Tk-SP is more stable in the presence of nonionic surfactants, suggesting that intramolecular interactions of ion pairs of Tk-SP may contribute to its stability. The improvement in the activity of Tk-SP in the presence of nonionic surfactants might be due to the stimulation of conformational changes in Tk-SP or the substrate, leading to activity gain.
Digestion of infectious MBH with Tk-SP
Previous reports have shown that alkaline pH is critical for effective digestion of PrPSc by subtilisin-type proteases; at pH 12, stable β-sheet structures may be significantly reduced or eliminated, allowing greater access or susceptibility to proteases [7, 8]. The ability of the enzymes to inactivate prions requires them to function at pH 12, a condition in which the conformation is accessible and susceptible to the protease. Tk-SP has been found to exhibit high activity at a wide range of pH between 7.0 and 11.5; additionally, the enzyme has been noted to be stable even at a pH of 12 . In the present study, digestion of infectious MBH was assessed at a pH of 8.0, and Tk-SP showed complete inactivation of PrPSc, suggesting that the enzyme can be useful for the inactivation of PrPSc not only in alkaline pH, but also in neutral pH. Thus, the remarkable characteristic of the ability of Tk-SP to degrade PrPSc completely indicates its potential application for the digestion of PrPSc.
In the present study, Tk-SP, a subtilisin homolog from Thermococcus kodakarensis, exhibited more than 100% of its activity and was highly stable in the presence of 0.1% (w/v) nonionic surfactants, but lost up to 20% of its activity in the presence of 0.01% (w/v) EDTA at 80°C. However, in the presence of 0.05% (w/v) nonionic surfactants, such as EMULGEN LS-114 or RHEODOL Tw-0120 V, and 0.01% (w/v) EDTA, Tk-SP retained almost its entire initial activity. Furthermore, the enzyme showed inherent stability in the presence of both surfactants and EDTA without site-directed mutagenesis or protein engineering. Moreover, Tk-SP was able to reduce the level of PrPSc as detected by western-blot analysis. Thus, Tk-SP can possibly be used as a detergent adjunct for industrial and healthcare applications.
The pET25b derivative for the overproduction of Pro-Tk-SP (Met + Ala1–Gly640) was constructed previously . E. coli BL21-codonPlus (DE3) was transformed with the pET25b derivative for the overproduction of Tk-SP. Pro-Tk-SP was processed into Tk-SP, a 44-kDa protein (Val114–Val539) during the maturation process, in which N-propeptide (Ala1–Ala113) is autoprocessed first, and then, the C-domain (Asp540–Gly640) is removed [14, 24, 25]. For overproduction, these transformants were grown at 37°C in NZCYM medium (Novagen) containing 50 μg/ml ampicillin and 35 μg/ml chloramphenicol. When the absorbance of 600 nm of the culture reached around 0.5, 1.0 mM isopropyl-β-D-thiogalactopyranoside (IPTG) was added to the culture medium and cultivation was continued for an additional 4 h. The cells were then harvested by centrifugation at 6000 × g for 10 min at 4°C and subjected to the following purification procedures at 4°C.
The cells were suspended in 20 mM Tris–HCl (pH 9.0), disrupted by sonication lysis, and centrifuged at 30,000 × g for 30 min at 4°C. The soluble fraction was collected and centrifuged at 30,000 × g for 30 min at 4°C to remove the precipitates. The protein was precipitated to 30% saturation by adding ammonium sulfate to the resultant supernatant. The pellet was collected by centrifugation at 30,000 × g for 30 min and dissolved in 20 mM Tris–HCl (pH 7.5). The resultant solution was dialyzed against 20 mM Tris–HCl (pH 7.5) and applied to a HiTrapQ HP column (GE Healthcare) equilibrated with the same buffer. The protein was eluted from the column by linearly increasing the NaCl concentration from 0 to 1.0 M. The fractions containing the protein were collected, dialyzed against 20 mM Tris–HCl (pH 7.5), concentrated using the Centricon (Millipore) ultrafiltration system, incubated at 80°C for 2 h, and stored at −20°C until further use.
The purity of the protein was analyzed by SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) using a 12% polyacrylamide gel, followed by staining with Coomassie Brilliant Blue (CBB). For these analyses, the sample was prepared by precipitating the protein using 1% (w/v) trichloroacetic acid (TCA), dissolving the pellet in SDS sample buffer (50 mM Tris–HCl (pH 6.8), 0.1 M dithiothreitol, 2% SDS, 10% (v/v) glycerol, and 0.005% (w/v) bromophenol blue), neutralizing the pH of the resultant solution, and boiling it for 5 min. The protein concentration was determined by UV absorption using a cell with an optical path length of 1 cm and an A280 value of 1.83 for 0.1% (1 mg/ml) Tk-SP solution. This value was calculated by using ε = 1526 and 5225/M/cm for Tyr and Trp, respectively, at 280 nm .
The enzymatic activity was determined by using azocasein (Sigma Chemical Co.) as the substrate at 80°C or 90°C. The reaction mixture (540 μl) contained 50 mM Tris–HCl (pH 7.5) and 0.2% (w/v) azocasein. Prior to the addition of Tk-SP, the reaction mixture was preincubated at the respective temperatures for 5 min. The enzymatic reaction was initiated by adding 100 nM Tk-SP and terminated by the addition of 400 μl of 1.5% (w/v) TCA. The reaction time was 20 min. Immediately after incubation, the samples were cooled at 4°C for 10 min. After centrifugation at 15,000 × g for 15 min at 4°C, an aliquot of the supernatant (640 μl) was withdrawn, mixed with 80 μl of 2 M NaOH, and measured for absorption at 440 nm (A440). The solubility of digested products of azocasein in the presence of detergents did not affect the activity assay in this condition. One unit of enzymatic activity is defined as the amount of enzyme that increases the A440 value of the assay reaction mixture by 0.1 in 1 min.
Effect of surfactants and EDTA on protease activity
To analyze the effects of surfactants and EDTA on the activity of Tk-SP, the enzyme’s activities were measured at 80°C or 90°C using azocasein as the substrate in the presence or absence of various concentrations of surfactants – four nonionic surfactants (EMULGEN 147, EMULGEN LS-114, EMULGEN PP-290, and RHEODOL Tw-0120 V; Kao Corporation, Tokyo, Japan), three anionic surfactants (EMAL TD, EMAL 20C (Kao), and SDS (Nacalai Tesque, Inc., Kyoto, Japan)), two cationic surfactants (QUARTAMIN 60 W and SANISOL C; Kao), and three amphionic surfactants (AMPHITOL 24B, AMPHITOL 20Y-B, and AMPHITOL 20 N; Kao) – and/or various concentrations of EDTA. The enzyme activity of a control without any surfactants and/or EDTA, incubated under similar conditions, was taken as 100%.
Enzymatic digestion of infectious MBH
Infectious 1% MBH in 200 mM Tris–HCl buffer (pH 8.0) was digested with 0.02 mg/ml (0.4 mM) Tk-SP in 0.5 M Tris–HCl buffer, and adjusted to pH 8.0 at 100°C for 1 h in the presence or absence of 1% SDS. Tk-SP was inactivated by adding 50 mM diisopropylfluorophosphate (DFP) to the sample. Positive control material at pH 8.0 was prepared in the same way, but in the absence of Tk-SP and SDS. SDS-PAGE was performed using 15% polyacrylamide gel. The samples were electrophoresed and then transferred to nitrocellulose membrane at constant amperage of 140 mA for 90 min. The membrane was immersed into 5% skim milk in 10 mM Tris-buffered saline (TBS) for 12 h to block nonspecific binding and washed with TBS containing 0.1% Tween 20. The membrane was then incubated with mouse anti-Prion protein monoclonal antibody (SAF-83) (Cayman Chemical Company; MI) diluted at a ratio of 1:1000 for 1 h at room temperature, followed by incubation with horseradish peroxidase-conjugated anti-mouse IgG (Sigma; St Louis, MO) for 1 h at room temperature. Immunoreactivity was visualized using ECL Plus Western Blotting Detection Reagents (GE Healthcare), according to the manufacturer’s instructions.
This work was supported in part by an Industrial Technology Research Grant Program (09A03002) from the New Energy and Industrial Technology Development Organization (NEDO) of Japan, and by a grant (24380055) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
- Zhu D, Wu Q, Wang N: Industrial enzymes. Comprehensive Biotechnology. Volume 3. Edited by: Muray M-Y. 2011, Waltham: Elsevier, 3-13. 2View ArticleGoogle Scholar
- Bryan PN: Protein engineering of subtilisin. Biochim Biophys Acta. 2000, 1543: 203-222. 10.1016/S0167-4838(00)00235-1.View ArticleGoogle Scholar
- Ward OP: Proteases. Comprehensive Biotechnology. Volume 3. Edited by: Muray M-Y. 2011, Waltham: Elsevier, 571-582. 2View ArticleGoogle Scholar
- Kirk O, Borchert TV, Fuglsang CC: Industrial enzyme applications. Curr Opin Biotechnol. 2002, 13: 345-351. 10.1016/S0958-1669(02)00328-2.View ArticleGoogle Scholar
- Gessesse A, Hatti-Kaul R, Gashe BA, Mattiasson B: Novel alkaline proteases from alkaliphilic bacteria grown on chicken feather. Enzyme Microb Technol. 2003, 32: 519-524. 10.1016/S0141-0229(02)00324-1.View ArticleGoogle Scholar
- Sellami-Kamoun A, Haddar A, Ali NE, Ghorbel-Frikha B, Kanoun S, Nasri M: Stability of thermostable alkaline protease from Bacillus licheniformis RP1 in commercial solid laundry detergent formulations. Microbiol Res. 2008, 163: 299-306. 10.1016/j.micres.2006.06.001.View ArticleGoogle Scholar
- Mcleod AH, Murdoch H, Dickinson J, Dennis MJ, Hall GA, Buswell CM, Carr J, Taylor DM, Sutton JM, Raven NDH: Proteolytic inactivation of the bovine spongiform encephalopathy agent. Biochem Biophys Res Commun. 2004, 317: 1165-1170. 10.1016/j.bbrc.2004.03.168.View ArticleGoogle Scholar
- Dickinson J, Murdoch H, Dennis MJ, Hall GA, Bott R, Crabb WD, Penet C, Sutton JM, Raven NDH: Decontamination of prion protein (BSE301V) using a genetically engineered protease. J Hosp Infect. 2009, 72: 65-70. 10.1016/j.jhin.2008.12.007.View ArticleGoogle Scholar
- Langeveld JPM, Wang JJ, Van de Wiel DFM, Shih GC, Garssen GJ, Bossers A, Shih JCH: Enzymatic degradation of prion protein in brain stem from infected cattle and sheep. J Infect Dis. 2003, 188: 1782-1789. 10.1086/379664.View ArticleGoogle Scholar
- Prusiner SB: Prions. Proc Natl Acad Sci USA. 1998, 95: 13363-13383. 10.1073/pnas.95.23.13363.View ArticleGoogle Scholar
- Wissmann C: The state of the prion. Nat Rev Microbiol. 2004, 2: 861-871. 10.1038/nrmicro1025.View ArticleGoogle Scholar
- Collinge J: Prion diseases of humans and animals: Their causes and molecular basis. Annu Rev Neurosci. 2001, 24: 519-550. 10.1146/annurev.neuro.24.1.519.View ArticleGoogle Scholar
- WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies. http://www.who.int/csr/resources/publications/bse/whocdscsraph2003.pdf,
- Peretz D, Supattapone S, Giles K, Vergara J, Freyman Y, Lessard P, Safar JG, Glidden DV, McCulloch C, Nguyen HOB, Scott M, DeArmond SJ, Prusiner SB: Inactivation of prions by acidic sodium dodecyl sulfate. J Virol. 2006, 80: 322-331. 10.1128/JVI.80.1.322-331.2006.View ArticleGoogle Scholar
- Atomi H, Fukui T, Kanai T, Morikawa M, Imanaka T: Description of Thermococcus kodakaraensis sp. nov., a well studied hyperthermophilic archaeon previously reported as Pyrococcus sp. KOD1. Archaea. 2004, 1: 263-267. 10.1155/2004/204953.View ArticleGoogle Scholar
- Pulido M, Saito K, Tanaka S, Koga Y, Morikawa M, Takano K, Kanaya S: Ca2+-dependent maturation of subtilisin from a hyperthermophilic archaeon, Thermococcus kodakaraensis: the propeptide is a potent inhibitor of the mature domain but is not required for its folding.Appl Environ Microbiol. 2006, 72: 4154-4162. 10.1128/AEM.02696-05.View ArticleGoogle Scholar
- Foophow T, Tanaka S, Koga Y, Takano K, Kanaya S: Subtilisin-like serine protease from hyperthermophilic archaeon Thermococcus kodakaraensis with N- and C-terminal propeptides. Protein Eng Des Sel. 2010, 23: 347-355. 10.1093/protein/gzp092.View ArticleGoogle Scholar
- Tanaka S, Saito K, Chon H, Matsumura H, Koga Y, Takano K, Kanaya S: Crystal structure of unautoprocessed precursor of subtilisin from a hyperthermophilic archaeon. J Biol Chem. 2007, 282: 8246-8255. 10.1074/jbc.M610137200.View ArticleGoogle Scholar
- Tanaka S, Matsumura H, Koga Y, Takano K, Kanaya S: Four new crystal structures of Tk-subtilisin in unautoprocessed, autoprocessed and mature forms: Insight into structural changes during maturation. J Mol Biol. 2007, 372: 1055-1069. 10.1016/j.jmb.2007.07.027.View ArticleGoogle Scholar
- Pulido MA, Koga Y, Takano K, Kanaya S: Directed evolution of Tk-subtilisin from a hyperthermophilic archaeon: identification of a single amino acid substitution responsible for low-temperature adaptation. Protein Eng Des Sel. 2007, 20: 143-153. 10.1093/protein/gzm006.View ArticleGoogle Scholar
- Pulido MA, Tanaka S, Sringiew C, You DJ, Matsumura H, Koga Y, Takano K, Kanaya S: Requirement of left-handed Glycine residue for high stability of the Tk-subtilisin propeptide as revealed by mutational and crystallographic analyses. J Mol Biol. 2007, 374: 1359-1373. 10.1016/j.jmb.2007.10.030.View ArticleGoogle Scholar
- Tanaka S, Takeuchi Y, Matsumura H, Koga Y, Takano K, Kanaya S: Crystal structure of Tk-subtilisin folded without propeptide: Requirement of propeptide for acceleration of folding. FEBS Lett. 2008, 582: 3875-3878. 10.1016/j.febslet.2008.10.025.View ArticleGoogle Scholar
- Tanaka S, Matsumura H, Koga Y, Takano K, Kanaya S: Identification of the interactions critical for propeptide-catalyzed folding of Tk-Subtilisin. J Mol Biol. 2009, 394: 306-319. 10.1016/j.jmb.2009.09.028.View ArticleGoogle Scholar
- Foophow T, Tanaka S, Angkawidjaja C, Koga Y, Takano K, Kanaya S: Crystal structure of a subtilisin homologue, Tk-SP, from Thermococcus kodakaraensis: Requirement of a C-terminal β-jelly roll domain for hyperstability. J Mol Biol. 2010, 400: 865-877. 10.1016/j.jmb.2010.05.064.View ArticleGoogle Scholar
- Sinsereekul N, Foophow T, Yamanouchi M, Koga Y, Takano K, Kanaya S: An alternative mature form of subtilisin homologue, Tk-SP, from Thermococcus kodakaraensis identified in the presence of Ca2+. FEBS Lett. 2011, 278: 1901-1911.View ArticleGoogle Scholar
- Kannan Y, Koga Y, Inoue Y, Haruki M, Takagi M, Imanaka T, Morikawa M, Kanaya S: Active subtilisin-like protease from a hyperthermophilic archaeon in a form with a putative prosequence. Appl Environ Microbiol. 2001, 67: 2445-2452. 10.1128/AEM.67.6.2445-2452.2001.View ArticleGoogle Scholar
- Tanaka S, Saito K, Chon H, Matsumura H, Koga Y, Takano K, Kanaya S: Crystallization and preliminary X-ray diffraction study of an active-site mutant of pro-Tk-Subtilisin from a hyperthermophilic archaeon. Acta Crystallogr Sect F. 2006, 62: 902-905. 10.1107/S1744309106030454.View ArticleGoogle Scholar
- Gupta R, Beg QK, Lorenz P: Bacterial alkaline proteases: molecular approaches and industrial applications. Appl Microbiol Biotechnol. 2002, 59: 15-32. 10.1007/s00253-002-0975-y.View ArticleGoogle Scholar
- Kumar CG, Takagi H: Microbial alkaline proteases: from a bioindustrial viewpoint. Biotechnol Adv. 1999, 17: 561-594. 10.1016/S0734-9750(99)00027-0.View ArticleGoogle Scholar
- Joo HS, Kumar CG, Park GC, Paik SR, Chang CS: Bleach-resistant alkaline protease produced by a Bacillus sp. Isolated from the Korean polychaete, Periserrula leucophryna. Process Biochem. 2004, 39: 1441-1447. 10.1016/S0032-9592(03)00260-7.View ArticleGoogle Scholar
- Japanese Society of Medical Instrumentation: Guideline for sterility assurance in healthcare setting. 2010, Tokyo: Ministry of Health, Labour and Welfare, JapanGoogle Scholar
- Otzen DE: Protein unfolding in detergents: effect of micelle structure, ionic strength, pH, and temperature. Biophys J. 2002, 83: 2219-2230. 10.1016/S0006-3495(02)73982-9.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.